Inside informationEnglish
Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biophytis
- Filed
- 11/09/2025, 06:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 079650_20250911